Colin M Barker

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. doi Feasibility of carotid artery stenting in patients with angiographic string sign
    Colin M Barker
    University of Texas Health Science Center, Houston, TX, USA
    Catheter Cardiovasc Interv 75:1104-9. 2010
  2. doi Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity
    Colin M Barker
    Division of Cardiology, University of Texas Medical School at Houston, Houston, Texas 77030, USA
    JACC Cardiovasc Interv 3:1001-7. 2010
  3. doi Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists
    Matthew J Price
    Division of Cardiology, University of Texas Medical School at Houston, Memorial Hermann Hospital Heart and Vascular Institute at the Texas Medical Center, USA
    Biomark Med 5:43-51. 2011
  4. doi Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease
    Michael S Lee
    Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, CA 90095 171715, USA
    Ann Thorac Surg 86:29-34. 2008

Detail Information

Publications4

  1. doi Feasibility of carotid artery stenting in patients with angiographic string sign
    Colin M Barker
    University of Texas Health Science Center, Houston, TX, USA
    Catheter Cardiovasc Interv 75:1104-9. 2010
    ..We describe our experience with CAS in a case series of symptomatic patients with severe carotid stenosis and angiographic SS...
  2. doi Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity
    Colin M Barker
    Division of Cardiology, University of Texas Medical School at Houston, Houston, Texas 77030, USA
    JACC Cardiovasc Interv 3:1001-7. 2010
    ..The objective of this study was to evaluate the antiplatelet effect of clopidogrel 150 mg/day in patients with high on-treatment reactivity (OTR) and to further assess this effect according to CYP2C19 genotype...
  3. doi Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists
    Matthew J Price
    Division of Cardiology, University of Texas Medical School at Houston, Memorial Hermann Hospital Heart and Vascular Institute at the Texas Medical Center, USA
    Biomark Med 5:43-51. 2011
    ..Over the past few years, a wealth of data have helped bring this promise closer to reality, and upcoming clinical trials of platelet function testing could at last bring personalized medicine into routine clinical practice...
  4. doi Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease
    Michael S Lee
    Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, CA 90095 171715, USA
    Ann Thorac Surg 86:29-34. 2008
    ..The ideal revascularization strategy (bypass surgery versus percutaneous coronary intervention [PCI]) for patients with cardiogenic shock in the setting of left main coronary artery disease is unknown...